• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GLAUKOS CORPORATION ISTENT INJECT W TRABECULAR MICRO-BYPASS SYSTEM MODEL IS2; INTRAOCULAR PRESSURE LOWERING IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GLAUKOS CORPORATION ISTENT INJECT W TRABECULAR MICRO-BYPASS SYSTEM MODEL IS2; INTRAOCULAR PRESSURE LOWERING IMPLANT Back to Search Results
Model Number IS2-JP
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Inflammation (1932); Fibrosis (3167)
Date of Event 08/28/2025
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that following uneventful bilateral cataract plus trabecular microbypass stent system procedures performed one (1) week apart, the patient presented postoperatively with fibrin observed in both eyes (ou).Per report, the patient underwent an anterior chamber washout and was treated with medication, which stabilized the patient's condition.Through follow-up, the following additional information was received.Per report, there was no further intervention required, and it is unknown what contributed to the fibrinous reaction.The patient status was described as intraocular pressure is stable and favorable with the event resolved.This report references the case of fibrin associated with the right eye (od).
 
Additional Manufacturer Narrative
Additional information: b3: awareness date used as event date.The device remains implanted in the patient; therefore, product testing on the actual device could not be performed.The device history record review of the manufacturing lot was performed and there were no non-conformities found to be related to the reported event.A review of the device labeling and associated risk documents was completed.Inflammation is identified in the labeling as a known inherent risk of trabecular micro-bypass stent procedure.The ifu adequately provides instructions for stent implantation, precautions, and warnings for the proper use and handling of the device.An adverse event appears to have occurred but does not appear to have been a problem with the device or the way it was used.The reported event (fibrin) is an established risk associated with use of the device, which is clearly documented.Based on the information received, the root cause of the reported event could not be conclusively identified.Mfr# reference: (b)(4).Reference report 2032546-2025-00090 for the case of fibrin associated with the left eye (os).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ISTENT INJECT W TRABECULAR MICRO-BYPASS SYSTEM MODEL IS2
Common Device Name
INTRAOCULAR PRESSURE LOWERING IMPLANT
Manufacturer (Section D)
GLAUKOS CORPORATION
229 avenida fabricante
san clemente CA 92672
Manufacturer (Section G)
GLAUKOS CORPORATION
229 avenida fabricante
san clemente CA 92672
Manufacturer Contact
brittany massey
229 avenida fabricante
san clemente, CA 92672
949367960
MDR Report Key23059007
Report Number2032546-2025-00089
Device Sequence Number8581866
Product Code OGO
UDI-Device Identifier00853704002487
UDI-Public01008537040024871032504017270331
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
P170043
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 09/15/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberIS2-JP
Device Lot Number325040
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/28/2025
Initial Report FDA Received Date09/15/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured05/09/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age88 YR
Patient SexMale
-
-